COMMUNIQUÉ RÉGLEMENTÉ publié le 05/05/2025 à 09:59, il y a 9 mois 7 jours Mersen: Number of shares and voting rights as of April 30, 2025 Mersen discloses total number of voting rights and shares in capital as of April 30, 2025, in compliance with French regulations. Mersen is a global expert in electrical power and advanced materials for high-tech industries Voting Rights Shares French Regulations Mersen Global Expert
COMMUNIQUÉ RÉGLEMENTÉ publié le 05/05/2025 à 09:59, il y a 9 mois 7 jours Mersen : nombre d'actions et de droits de vote au 30 avril 2025 Déclaration des droits de vote et du capital de Mersen au 30 avril 2025. Présence mondiale dans les spécialités électriques et matériaux avancés pour les industries High-Tech Capital Déclaration Mersen Industries High-Tech Matériaux Avancés
COMMUNIQUÉ DE PRESSE publié le 05/05/2025 à 09:40, il y a 9 mois 7 jours Ministry of Foreign and European Affairs Showcases Decent Cybersecurity at Innovation Day on Cybersecurity Ministry of Foreign and European Affairs showcases Decent Cybersecurity's post-quantum solutions at Innovation Day on Cybersecurity, highlighting Slovakia's leadership in advanced technologies and public-private partnerships Cybersecurity Innovation Day Slovakia Decent Cybersecurity Post-quantum Solutions
COMMUNIQUÉ DE PRESSE publié le 05/05/2025 à 09:15, il y a 9 mois 7 jours Accelleron focuses on growth in injection systems and invests in Italy Accelleron's subsidiary OMT invests in Italy to expand production capacities and strengthen technological leadership in fuel injection systems, aiming to double revenue to USD 150 million by 2029. Total investments of USD 80 million planned Italy Investment Accelleron Fuel Injection OMT
COMMUNIQUÉ DE PRESSE publié le 05/05/2025 à 09:13, il y a 9 mois 7 jours Roquette Announces a New Organizafion following the Acquisifion of IFF Pharma Solufions Roquefte successfully completes the acquisition of IFF Pharma Solutions, strengthening its position in the pharmaceutical industry and reinforcing commitment to innovation Acquisition Innovation Pharmaceutical Industry IFF Pharma Solutions Roquefte
COMMUNIQUÉ DE PRESSE publié le 05/05/2025 à 09:05, il y a 9 mois 7 jours BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization BioNxt Solutions Inc. announces acceptance of its first national level patent filing by Eurasian Patent Organization, covering sublingual drug delivery for neurodegenerative diseases BioNxt Solutions Inc. Patent Filing Neurodegenerative Diseases Sublingual Delivery Eurasian Patent Organization
COMMUNIQUÉ DE PRESSE publié le 05/05/2025 à 08:35, il y a 9 mois 7 jours Eurobattery Minerals passed the first phase of evaluation in European Funding Call Eurobattery Minerals AB's funding application to the 'ERMA Booster Call 2025' program passes first evaluation phase, advancing to next stage. Company emphasizes project's importance for Europe's raw materials resilience and competitiveness Europe Eurobattery Minerals AB Raw Materials ERMA Booster Call 2025 Funding Application
COMMUNIQUÉ RÉGLEMENTÉ publié le 05/05/2025 à 08:30, il y a 9 mois 7 jours NFL Biosciences annonce les résultats d’une nouvelle étude menée avec le CEA permettant de mieux décrire l’effet de NFL-101, son traitement first in class contre l’addiction au tabac, mettant notamment en évidence son activité prolongée NFL Biosciences annonce les résultats d’une nouvelle étude menée avec le CEA sur l'effet prolongé de NFL-101 contre l'addiction au tabac. Nouvelles données sur les zones cérébrales ciblées par le traitement NFL Biosciences NFL-101 CEA Étude Addiction Au Tabac
COMMUNIQUÉ RÉGLEMENTÉ publié le 05/05/2025 à 08:30, il y a 9 mois 7 jours NFL Biosciences announces results from a new study conducted with the CEA providing further insight into the effects of NFL-101, its first-in-class treatment for tobacco addiction, and highlighting its prolonged activity NFL Biosciences announces results from a new study with CEA on NFL-101, a treatment for tobacco addiction, highlighting prolonged activity & unique effect, showcased via PET imaging NFL Biosciences CEA Study NFL-101 Tobacco Addiction Prolonged Activity
COMMUNIQUÉ DE PRESSE publié le 05/05/2025 à 08:30, il y a 9 mois 7 jours Inventiva secures the €116 million second tranche of its structured financing of up to €348 million
Publié le 12/02/2026 à 21:30, il y a 4 heures 33 minutes Aéroports de Paris SA - 2026 Airport charges in Paris
Publié le 12/02/2026 à 21:30, il y a 4 heures 33 minutes Aéroports de Paris SA - Processus d'homologation tarifaire 2026
Publié le 12/02/2026 à 17:45, il y a 8 heures 19 minutes MR.BRICOLAGE SA: ENTERING INTO A NEW SYNDICATED CREDIT FACILITY
Publié le 13/02/2026 à 00:20, il y a 1 heure 44 minutes Southern Energy Corp. Completes US$23.5 Million Financings and Royalty Sale
Publié le 13/02/2026 à 00:10, il y a 1 heure 54 minutes Irving Resources Announces Closing of First Tranche of Non-Brokered Private Placement
Publié le 12/02/2026 à 23:25, il y a 2 heures 39 minutes The Caldwell Partners International Announces Results of Vote for Election of Directors
Publié le 12/02/2026 à 22:00, il y a 4 heures 4 minutes Electrovaya Reports Fiscal Year Q1 2026 Results
Publié le 12/02/2026 à 19:18, il y a 6 heures 46 minutes Verdera Energy Closes $20 Million Financing and Provides Update to Proposed Qualifying Transaction and Listing on the TSX-V
Publié le 12/02/2026 à 21:16, il y a 4 heures 48 minutes Form 8.3 - The Vanguard Group, Inc.: JTC plc
Publié le 12/02/2026 à 21:15, il y a 4 heures 49 minutes Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Publié le 12/02/2026 à 21:14, il y a 4 heures 50 minutes Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Publié le 12/02/2026 à 21:13, il y a 4 heures 50 minutes Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Publié le 12/02/2026 à 21:13, il y a 4 heures 51 minutes Form 8.3 - The Vanguard Group, Inc.: Oxford Biomedica plc